US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 2.260
  • -0.050-2.16%
Close Mar 28 16:00 ET
  • 2.220
  • -0.040-1.77%
Post 20:01 ET
344.26MMarket Cap-25.11P/E (TTM)

Heron Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
61.68%-22.53M
-579.84%-11.78M
136.73%3.37M
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
Net income from continuing operations
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
Operating gains losses
598.88%4.38M
----
----
----
----
121.55%627K
189.00%604K
--0
----
----
Depreciation and amortization
-14.04%2.49M
-18.74%581K
-20.08%581K
-13.26%641K
-4.04%689K
0.35%2.9M
-9.61%715K
2.97%727K
10.13%739K
-0.42%718K
Other non cash items
183.48%961K
84.05%300K
416.44%377K
176.92%144K
174.51%140K
67.82%339K
226.00%163K
40.38%73K
4.00%52K
2.00%51K
Change In working capital
-264.40%-27.6M
-318.32%-18.34M
-50.13%4.25M
-986.53%-3.42M
-1,811.36%-10.09M
259.81%16.79M
129.45%8.4M
224.00%8.53M
-97.71%386K
-106.59%-528K
-Change in receivables
-131.75%-18.74M
-423.73%-11.84M
-48.29%6.67M
66.78%-8.39M
-962.73%-5.19M
51.13%-8.09M
137.10%3.66M
784.24%12.9M
-3,255.63%-25.25M
110.72%601K
-Change in inventory
-188.66%-11.05M
-6,900.00%-7.21M
-217.97%-3.09M
-105.26%-391K
-114.44%-363K
301.31%12.46M
95.59%-103K
-71.19%2.62M
253.38%7.44M
131.08%2.51M
-Change in prepaid assets
-164.35%-9.93M
-226.06%-6.16M
-2,330.23%-3.84M
-96.95%289K
-124.50%-222K
1,427.33%15.43M
203.58%4.89M
-89.43%172K
110.15%9.46M
323.70%906K
-Change in payables and accrued expense
502.46%12.12M
18,171.05%6.87M
162.98%4.51M
-41.98%5.07M
4.99%-4.32M
-126.82%-3.01M
99.67%-38K
54.42%-7.16M
-46.84%8.73M
-120.57%-4.55M
Cash from discontinued investing activities
Operating cash flow
61.68%-22.53M
-579.84%-11.78M
136.73%3.37M
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
Investing cash flow
Cash flow from continuing investing activities
4.00%18.71M
229.22%11.42M
117.10%3.97M
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
Net PPE purchase and sale
-9.60%-1.68M
-157.81%-611K
45.65%-431K
-129.14%-637K
--0
4.13%-1.53M
42.34%-237K
-744.72%-793K
13.66%-278K
77.33%-224K
Net investment purchase and sale
4.43%20.39M
239.89%12.03M
119.62%4.4M
-80.11%2.69M
-96.55%1.28M
1,231.34%19.53M
-453.58%-8.6M
37.99%-22.43M
-32.78%13.5M
210.52%37.06M
Cash from discontinued investing activities
Investing cash flow
4.00%18.71M
229.22%11.42M
117.10%3.97M
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
Financing cash flow
Cash flow from continuing financing activities
-98.26%940K
112.56%423K
-99.97%14K
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
Net issuance payments of debt
--0
--0
----
----
----
--24.35M
--0
----
----
----
Net common stock issuance
--0
--0
----
----
----
-60.40%29.76M
--0
----
----
----
Proceeds from stock option exercised by employees
46,900.00%940K
112.56%423K
104.55%14K
54.23%492K
105.29%11K
102.33%2K
-56.46%199K
-39.37%-308K
1.27%319K
67.35%-208K
Cash from discontinued financing activities
Financing cash flow
-98.26%940K
112.56%423K
-99.97%14K
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
Net cash flow
Beginning cash position
86.65%28.68M
-26.16%25.74M
36.58%18.39M
-24.51%20.45M
86.65%28.68M
-83.03%15.36M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
-83.03%15.36M
Current changes in cash
-121.60%-2.88M
100.99%61K
-65.63%7.36M
84.85%-2.06M
-170.16%-8.23M
117.71%13.31M
82.37%-6.18M
1,069.87%21.4M
-64.15%-13.63M
134.87%11.73M
End cash Position
-10.03%25.8M
-10.03%25.8M
-26.16%25.74M
36.58%18.39M
-24.51%20.45M
86.65%28.68M
86.65%28.68M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
Free cash flow
59.83%-24.24M
-663.17%-12.42M
129.48%2.94M
80.90%-5.24M
62.12%-9.52M
59.44%-60.33M
105.81%2.21M
73.13%-9.97M
4.36%-27.44M
44.15%-25.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 61.68%-22.53M-579.84%-11.78M136.73%3.37M83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M
Net income from continuing operations 87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M
Operating gains losses 598.88%4.38M----------------121.55%627K189.00%604K--0--------
Depreciation and amortization -14.04%2.49M-18.74%581K-20.08%581K-13.26%641K-4.04%689K0.35%2.9M-9.61%715K2.97%727K10.13%739K-0.42%718K
Other non cash items 183.48%961K84.05%300K416.44%377K176.92%144K174.51%140K67.82%339K226.00%163K40.38%73K4.00%52K2.00%51K
Change In working capital -264.40%-27.6M-318.32%-18.34M-50.13%4.25M-986.53%-3.42M-1,811.36%-10.09M259.81%16.79M129.45%8.4M224.00%8.53M-97.71%386K-106.59%-528K
-Change in receivables -131.75%-18.74M-423.73%-11.84M-48.29%6.67M66.78%-8.39M-962.73%-5.19M51.13%-8.09M137.10%3.66M784.24%12.9M-3,255.63%-25.25M110.72%601K
-Change in inventory -188.66%-11.05M-6,900.00%-7.21M-217.97%-3.09M-105.26%-391K-114.44%-363K301.31%12.46M95.59%-103K-71.19%2.62M253.38%7.44M131.08%2.51M
-Change in prepaid assets -164.35%-9.93M-226.06%-6.16M-2,330.23%-3.84M-96.95%289K-124.50%-222K1,427.33%15.43M203.58%4.89M-89.43%172K110.15%9.46M323.70%906K
-Change in payables and accrued expense 502.46%12.12M18,171.05%6.87M162.98%4.51M-41.98%5.07M4.99%-4.32M-126.82%-3.01M99.67%-38K54.42%-7.16M-46.84%8.73M-120.57%-4.55M
Cash from discontinued investing activities
Operating cash flow 61.68%-22.53M-579.84%-11.78M136.73%3.37M83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M
Investing cash flow
Cash flow from continuing investing activities 4.00%18.71M229.22%11.42M117.10%3.97M-84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M
Net PPE purchase and sale -9.60%-1.68M-157.81%-611K45.65%-431K-129.14%-637K--04.13%-1.53M42.34%-237K-744.72%-793K13.66%-278K77.33%-224K
Net investment purchase and sale 4.43%20.39M239.89%12.03M119.62%4.4M-80.11%2.69M-96.55%1.28M1,231.34%19.53M-453.58%-8.6M37.99%-22.43M-32.78%13.5M210.52%37.06M
Cash from discontinued investing activities
Investing cash flow 4.00%18.71M229.22%11.42M117.10%3.97M-84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M
Financing cash flow
Cash flow from continuing financing activities -98.26%940K112.56%423K-99.97%14K54.23%492K105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K
Net issuance payments of debt --0--0--------------24.35M--0------------
Net common stock issuance --0--0-------------60.40%29.76M--0------------
Proceeds from stock option exercised by employees 46,900.00%940K112.56%423K104.55%14K54.23%492K105.29%11K102.33%2K-56.46%199K-39.37%-308K1.27%319K67.35%-208K
Cash from discontinued financing activities
Financing cash flow -98.26%940K112.56%423K-99.97%14K54.23%492K105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K
Net cash flow
Beginning cash position 86.65%28.68M-26.16%25.74M36.58%18.39M-24.51%20.45M86.65%28.68M-83.03%15.36M-30.89%34.86M-72.31%13.46M-52.40%27.09M-83.03%15.36M
Current changes in cash -121.60%-2.88M100.99%61K-65.63%7.36M84.85%-2.06M-170.16%-8.23M117.71%13.31M82.37%-6.18M1,069.87%21.4M-64.15%-13.63M134.87%11.73M
End cash Position -10.03%25.8M-10.03%25.8M-26.16%25.74M36.58%18.39M-24.51%20.45M86.65%28.68M86.65%28.68M-30.89%34.86M-72.31%13.46M-52.40%27.09M
Free cash flow 59.83%-24.24M-663.17%-12.42M129.48%2.94M80.90%-5.24M62.12%-9.52M59.44%-60.33M105.81%2.21M73.13%-9.97M4.36%-27.44M44.15%-25.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More